Diagnostics and prognostic potential of current biomarkers in heart failure with preserved ejection fraction: a systematic review and meta-analysis

Hao Chen, Michael Chhor, Benjamin Rayner, Kristine McGrath, Lana McClements
doi: https://doi.org/10.1101/2020.04.18.20070482

Article Information

doi 
https://doi.org/10.1101/2020.04.18.20070482
History 
  • April 21, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Hao Chen1,2,
  2. Michael Chhor1,
  3. Benjamin Rayner2,
  4. Kristine McGrath1 and
  5. Lana McClements1,*
  1. 1School of Life Sciences, Faculty of Science, University of Technology Sydney, NSW, Australia
  2. 2Heart Research Institute, Sydney Medical School, University of Sydney, NSW, Australia
  1. ↵*Corresponding author; email: lana.mcclements{at}uts.edu.au
Back to top
Posted April 21, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Diagnostics and prognostic potential of current biomarkers in heart failure with preserved ejection fraction: a systematic review and meta-analysis
Hao Chen, Michael Chhor, Benjamin Rayner, Kristine McGrath, Lana McClements
medRxiv 2020.04.18.20070482; doi: https://doi.org/10.1101/2020.04.18.20070482
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area